Market Place
Sourcing Support
Innocoll and DURECT Announce U.S. launch of POSIMIR®
26 Sep 2022 //
PRNEWSWIRE
Innocoll to Publish Positive Results from Pivotal Clinical Trial of POSIMIR
06 Jul 2022 //
BUSINESSWIRE
Innocoll Shows Positive Topline Results For XARACOLL implant in Phase 3 Study
02 Mar 2022 //
BUSINESSWIRE
Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)
29 Oct 2020 //
PRNEWSWIRE
Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)
29 Oct 2020 //
PRNEWSWIRE
FDA Approves XARACOLL® (bupivacaine HCl), a Non-opioid, Drug-device Treatment
31 Aug 2020 //
BIOSPACE
Innocoll Holdings Announces FDA Acceptance ofnda for XARACOLL®
27 Mar 2020 //
PR NEWSWIRE
Innocoll Holdings Announces FDA Acceptance of New Drug Application for XARACOLL®
26 Mar 2020 //
PRNEWSWIRE
Innocoll Holdings Resubmits NDA to FDA for XARACOLL®
27 Feb 2020 //
PR NEWSWIRE
Innocoll Receives Refusal to File Letter from USFDA for Xaracoll NDA
29 Dec 2016 //
GLOBENEWSWIRE
Innocoll Announces Top-Line Data From Phase 3 Trials
03 Nov 2016 //
GLOBENEWSWIRE
Innocoll Holdings plc to Present at the Morgan Stanley Global Healthcare
07 Sep 2016 //
GLOBENEWSWIRE
Heron Therapeutics shares jump after pain drug succeeds in trial
22 Sep 2015 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.